Clinical trial
Study to Evaluate Smecta® vs Placebo on the Time to Recovery Following an Acute…
NCT00276328 · Ipsen, Industry · Completed
Key facts
| NCT number | NCT00276328 |
|---|---|
| Title | Study to Evaluate Smecta® vs Placebo on the Time to Recovery Following an Acute Diarrhoea Episode in Adults |
| Official title | Efficacy of Diosmectite (Smecta®) in the Treatment of Acute Diarrhoea in Adults. A Multicentre, Randomised, Double Blind, Placebo Controlled, Parallel Groups Study. |
| Lead sponsor | Ipsen, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Diarrhea |
| Intervention type | Drug |
| Interventions | Diosmectite (Smecta®) |
| Enrollment | 346 |
| Start date | Jan 1, 2005 |
| Completion | Jul 1, 2006 |
| First posted | Jan 13, 2006 |
| Last update posted | Apr 28, 2020 |
| Countries | Morocco, Tunisia |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: